Lombard Odier Asset Management (USA)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.58M Hold
125,000
0.79% 28
2025
Q4
$6.74M Hold
125,000
0.63% 33
2025
Q3
$5.64M Hold
125,000
0.38% 42
2025
Q2
$5.79M Hold
125,000
0.44% 43
2025
Q1
$7.62M Hold
125,000
0.6% 31
2024
Q4
$7.07M Buy
+125,000
New +$6.98M 0.52% 37

Other funds holding BMY

Lombard Odier Asset Management (USA)'s BMY Position: Q1 2022 in Review

Lombard Odier Asset Management (USA) sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 60,000 shares — an estimated $3.74M sold.

Lombard Odier Asset Management (USA) first reported a position in BMY in Q2 2013 and held it in 7 quarters. The position peaked at $22.1M in Q1 2014. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

  • Lombard Odier Asset Management (USA) reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 60,000 Bristol-Myers Squibb shares in Q1 2022, an estimated $3.74M.
  • Lombard Odier Asset Management (USA) first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 7 quarters.
  • Lombard Odier Asset Management (USA)'s Bristol-Myers Squibb position peaked at $22.1M in Q1 2014.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2022, filed 16 May 2022.